Multiple sclerosis (MS) is a chronic autoimmune disorder affecting movement, sensation, and bodily functions. It is caused by destruction of the myelin insulation covering nerve fibers (neurons) in the central nervous system (brain and spinal cord).
Stem cells from fat tissue offer hope for Multiple sclerosis MS treatment. – A preliminary study on the use of stem cells obtained from a patient’s own adipose tissue in the treatment of multiple sclerosis (MS) has shown promising results.
Genetic study shows direct link between vitamin D and MS susceptibility ‘gene’ – Researchers have found evidence that a direct interaction between vitamin D and a common genetic variant alters the risk of developing multiple sclerosis (MS).
If Brain MRI shows signs of Multiple sclerosis (MS), will the disease develop? – With more and more people having brain MRIs for various reasons, doctors are finding people whose scans show signs of multiple sclerosis (MS) even though they have no symptoms of the disease.
Research indicates drug alemtuzumab not only stops the Multiple sclerosis disease from advancing but may also restore lost function in many Multiple sclerosis patients. – A drug which was developed in Cambridge and initially designed to treat a form of leukaemia has also proven effective against combating the debilitating neurological disease multiple sclerosis (MS).
Smoking marijuana can have a harmful effect on the cognitive skills of people with multiple sclerosis (MS). – People with multiple sclerosis (MS) who smoke marijuana are more likely to have emotional and memory problems, according to research published February 13, 2008, in the online edition of Neurology, the medical journal of the American Academy of Neurology.
Genentech Inc. and Biogen Idec Inc.’s cancer drug Rituxan (rituximab) reduced brain lesions in multiple sclerosis patients. – A drug therapy, using rituximab, dramatically reduced the number of inflammatory lesions that form along nerve fibers in brains of multiple sclerosis patients, revealed by researchers recently.
Combining a medication currently used to treat multiple sclerosis with an antibiotic may slow the progress of the disease in multiple sclerosis patients.
– A preliminary study suggests that combining a medication currently used to treat multiple sclerosis with an antibiotic may slow the progress of the disease, according to an article posted online today that will appear in the February 2008 print issue of Archives of Neurology, one of the JAMA/Archives journals.
